Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 151-157

  Kašpárek, Tomáš ^a   Přikryl, Radovan ^a   Mikl, Michal ^b   Schwarz, Daniel ^a,b   Češková, Eva ^a   Krupa, Petr ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

Author keywords

First episode; Optimized voxel based morphometry; Prefrontal cortex; Schizophrenia

Indexed keywords

AMISULPRIDE; ANTIPARKINSON AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN; BRAIN SIZE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FIRST EPISODE SCHIZOPHRENIA; GRAY MATTER; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL INSTRUMENTATION; MENTAL DISEASE; MONOTHERAPY; MORPHOMETRICS; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TEMPORAL LOBE;

ADULT; ANTIPSYCHOTIC AGENTS; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 33845665719     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.08.011     Document Type: Article

References (35)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24 2 (1998) 189-202
2. Andreasen N.C., Paradiso S., and O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophr Bull 24 2 (1998) 203-218
3. Ashburner J., and Friston K.J. Voxel-based morphometry - the methods. Neuroimage 11 6 (2000) 805-821
4. Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull 23 3 (1997) 423-435
5. Davatzikos C., Genc A., Xu D., and Resnick S.M. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage 14 (2001) 1361-1369
6. Davidson L.L., and Heinrichs R.W. Quantification of frontal and temporal lobe brain imaging findings in schizophrenia: a meta-analysis. Psych Res Neuroimaging 122 (2003) 69-87
7. Deicken R.F., Pegues M., and Amend D. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr Res 37 (1999) 217-223
8. DeLisi L.E., Sakuma M., Tew W., Dushner M., Hoff A.L., and Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res Neuroimaging 74 (1997) 129-140
9. Farrow T.F.D., Whitford T.J., Williams L.M., Gomes L., and Harris A.W.F. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58 9 (2005) 713-723
10. Garver D.L., Holcomb J.A., and Christensen J.D. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol Psychiatry 58 1 (2005) 62-66
11. Goldman-Rakic P., and Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23 3 (1997) 437-458
12. Good C.D., Johnsrude I., Ashburner J., Henson R.N.A., Friston K.J., and Frackowiak R.S.J. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. NeuroImage 14 (2001) 685-700
13. Good C., Scahill R., Fox N., Ashburner J., Friston K., Chan D., et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 17 (2002) 29-46
14. Honea R., Crow T.J., Passingham D., and Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162 (2005) 2233-2245
15. Jayakumar P.N., Venkatasubramanian G., Gangadhar B.N., Janakiramaiah N., and Keshavan M.S. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 4 (2005) 587-591
16. Job D.E., Whalley H.C., McConnell C., Glabus M., Johnstone E.C., and Lawrie S.M. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. NeuroImage 17 (2002) 880-889
17. Kay S.R., Fiszbein A., and Opler L.A. Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
18. Kubicki M., Shenton M.E., Salisbury D.F., Hirayasu Y., Kasai K., Kikinis R., et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 17 4 (2002) 1711-1719
19. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., et al. Antipsychotic drug effects on brain morphology in first-episode schizophrenia. Arch Gen Psychiatry 62 4 (2005) 361-370
20. Massana G., Salgado-Pineda P., Junque C., Perez M., Baeza I., Pons A., et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidon. J Clin Psychopharmacol 25 2 (2005) 111-117
21. Narr K.L., Thompson P.M., Sharma T., Moussai J., Blanton R., Anvar B., et al. Three-dimensional mapping of tempor-limbic regions and the lateral ventricles in schizophrenia: gender effects. Biol Psychiatry 50 (2001) 84-97
22. Nelson M.D., Saykin A.J., Flashman L.A., and Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a metaanalytic study. Arch Gen Psychiatry 55 (1998) 433-440
23. Salgado-Pineda P., Baeza I., Pérez-Gómez M., Vendrell P., Junqué C., Bargalló N., et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. NeuroImage 19 (2003) 365-375
24. Salmond C.H., Ashburner J., Vargha-Khadem F., Connelly A., Gadian D.G., and Friston K.J. The precision of anatomical normalization in the medial temporal lobe using spatial basis function. Neuroimage 17 (2002) 507-512
25. Senjem M.L., Gunter J.L., Shiung M.M., Petersen R.C., and Jack C.R. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. NeuroImage 26 (2005) 600-608
26. Sowell E.R., Thompson P.M., Holmes C.J., Batth R., Jernigan T.L., and Toga A.W. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. NeuroImage 9 (1999) 587-597
27. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labelling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single subject brain. Neuroimage 15 (2002) 273-289
28. Velakoulis D., Wood S.J., Smith D.J., Soulsby B., Brewer W., Leeton L., et al. Increased duration of illness is associated with reduced volume in right medial temporal/anterior cingulate gray matter in patients with chronic schizophrenia. Schizophr Res 57 1 (2002) 43-49
29. Velakoulis D., Wood S.J., Wong M.T.H., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis. Arch Gen Psychiatry 63 (2006) 139-149
30. Vita A., De Peri L., Silenzi C., and Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82 (2006) 75-88
31. Weinberger D.R. Dopamine, the prefrontal cortex, and genetic mechanism of schizophrenia. In: Kapur S., and Lecrubier Y. (Eds). Dopamine in the pathophysiology and treatment of schizophrenia (2003), Martin Dunitz, London 129-154
32. Weinberger D.R., and McClure R.K. Neurotoxicity, neuroplasticity and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch Gen Psychiatry 59 (2002) 553-558
33. Whitford T.J., Farrow T.F., Gomes L., Brennan J., Harris A.W., and Williams L.M. Gray matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res 139 3 (2005) 229-238
34. Wilke M., Kaufmann C., Grabner A., Pütz B., Wetter T.C., and Auer D.P. Gray matter changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. NeuroImage 13 (2001) 814-824
35. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., David A.S., Murray R.M., and Bullmore E.R. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (2000) 16-25